Skip to main content

Carolyn M. Sue, MBBS, PhD, FRACP

Executive Director, Professor and Director of Neurogenetics at Kolling Institute, University of Sydney

Location: Sydney NSW Australia

Carolyn Sue, MBBS, PhD, FRACP, is the Executive Director of the Kolling Institute and Professor and Director of Neurogenetics at Royal North Shore Hospital, University of Sydney. Dr. Sue is a clinician-scientist, recognized for her expertise in mitochondrial function as it relates to mitochondrial and other neurodegenerative diseases. Her research team combines the use of genomics, molecular neuroscience, and adult stem cell models to identify pathogenic mechanisms and develop targeted therapies for Parkinson’s disease and other related neurodegenerative disorders. Her contributions to the field have been in gene discovery, biomarker development, application of next generation sequencing protocols and bioinformatic pipeline development for improved diagnostic pathways, and the identification novel targets for the treatment of Parkinson’s disease.

Associated Grants

  • Evaluating a Gene Therapy that Restores Mitochondrial Function as a Treatment for Parkinson’s Disease


  • In Vivo Approach to Elucidate the Pathobiology of Parkinson’s-associated Genes Using Human Diseased Neurons


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.